Literature DB >> 8144867

Growth hormone response to oral clonidine test in normal and short children.

S Loche1, M Cappa, E Ghigo, A Faedda, A Lampis, D Carta, C Pintor.   

Abstract

We evaluated the growth hormone (GH) response to an acute clonidine test (0.15 mg/m2 po) in 30 normal prepubertal children (stature between the 3rd and 97th centile), in 29 short children (stature < 3rd centile for age) with height velocity (HV) > 10th centile and in 20 short children with HV < 10th centile. The three groups had comparable chronological ages. After clonidine administration mean peak GH levels were similar in the three groups (19.4 +/- 9.8, 17.7 +/- 8.8 and 14.6 +/- 8.9 micrograms/l, mean +/- SD, respectively). By choosing 10 micrograms/l as the limit for a normal response we found that stimulated GH levels had a sensitivity of 50% and a specificity of 83% in identifying children with suspected GHD (short children with subnormal HV). The diagnostic accuracy was almost superimposable, for cut-off values of 10 and 12 micrograms/l. Eight of the 10 children with subnormal HV and a GH peak < 10 micrograms/l had a GH peak < 10 micrograms/l also after a second stimulation test. Six of the 29 short children with normal HV had a GH peak < 10 micrograms/l. Only one of them had a GH peak < 10 micrograms/l after a second stimulation test. Five of the normal children had peak GH levels < 10 micrograms/l. These results indicate that HV is a useful variable to predict the GH response to an acute GH stimulus, since the great majority of children with a normal growth rate had a normal GH response to at least one stimulation test.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8144867     DOI: 10.1007/BF03348953

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  What is a normal stimulated growth hormone concentration?

Authors:  M T Dattani; P J Pringle; P C Hindmarsh; C G Brook
Journal:  J Endocrinol       Date:  1992-06       Impact factor: 4.286

2.  Somatomedin-C and the assessment of growth.

Authors:  L E Underwood; A J D'Ercole; J J Van Wyk
Journal:  Pediatr Clin North Am       Date:  1980-11       Impact factor: 3.278

3.  Do short children secrete insufficient growth hormone?

Authors:  Z Zadik; S A Chalew; S Raiti; A A Kowarski
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

4.  Growth hormone neurosecretory dysfunction. A treatable cause of short stature.

Authors:  B E Spiliotis; G P August; W Hung; W Sonis; W Mendelson; B B Bercu
Journal:  JAMA       Date:  1984-05-04       Impact factor: 56.272

5.  Diagnostic limitations of spontaneous growth hormone measurements in normally growing prepubertal children.

Authors:  R Lanes
Journal:  Am J Dis Child       Date:  1989-11

6.  Somatotropic function in short stature: evaluation by integrated auxological and hormonal indices in 214 children. The Italian Collaborative Group of Neuroendocrinology.

Authors:  F Dammacco; M F Boghen; F Camanni; M Cappa; C Ferrari; E Ghigo; G Giordano; S Loche; F Minuto; M Mucci
Journal:  J Clin Endocrinol Metab       Date:  1993-07       Impact factor: 5.958

7.  Efficacy of insulin-like growth factor I levels in predicting the response to provocative growth hormone testing.

Authors:  P D Lee; D M Wilson; L Rountree; R L Hintz; R G Rosenfeld
Journal:  Pediatr Res       Date:  1990-01       Impact factor: 3.756

8.  Analyses of 24-hour growth hormone profiles in children: relation to growth.

Authors:  K Albertsson-Wikland; S Rosberg
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

9.  Oral clonidine as a growth hormone stimulation test.

Authors:  I Gil-Ad; E Topper; Z Laron
Journal:  Lancet       Date:  1979-08-11       Impact factor: 79.321

10.  The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency.

Authors:  S R Rose; J L Ross; M Uriarte; K M Barnes; F G Cassorla; G B Cutler
Journal:  N Engl J Med       Date:  1988-07-28       Impact factor: 91.245

View more
  2 in total

1.  Clonidine-stimulated growth hormone concentrations (cut-off values) measured by immunochemiluminescent assay (ICMA) in children and adolescents with short stature.

Authors:  Maria de Fátima Borges; Flávia Carolina Cândida Teixeira; Aline Karin Feltrin; Karina Alvarenga Ribeiro; Gabriel Antonio Nogueira Nascentes; Elisabete Aparecida Mantovani Rodrigues Resende; Beatriz Pires Ferreira; Adriana Paula Silva; Heloísa Marcelina Cunha Palhares
Journal:  Clinics (Sao Paulo)       Date:  2016-04       Impact factor: 2.365

2.  Influence of biochemical diagnosis of growth hormone deficiency on replacement therapy response and retesting results at adult height.

Authors:  Giulia Rodari; E Profka; F Giacchetti; I Cavenaghi; M Arosio; C Giavoli
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.